Related Experiment Videos
Gene polymorphisms in the Quebec population: a risk to develop hypertriglyceridemia.
Christophe Garenc1, Samuel Aubert, Jerôme Laroche
1Department of Medicine, Lipid Research Center (CRML), Centre de Recherche du Centre Hospitalier de l'Université Laval du CHUQ, TR-93, Laval University, Sainte-Foy, Que., Canada G1V 4G2.
Biochemical and Biophysical Research Communications
|April 25, 2006
Summary
Genetic screening for lipoprotein lipase (LPL) gene mutations D9N and S447X is crucial. These mutations impact hypertriglyceridemia risk in Eastern Québec populations.
Area of Science:
- Genetics
- Metabolic Disorders
- Population Health
Background:
- Lipoprotein lipase (LPL) gene mutations P207L and G188E cause LPL deficiency and hypertriglyceridemia risk in Eastern Québec.
- Understanding the prevalence of various LPL and related gene polymorphisms is essential for assessing population health.
Purpose of the Study:
- Determine allele frequencies of LPL, APOE, PPARalpha, and PPARgamma2 single nucleotide polymorphisms (SNPs) in Québec City.
- Compare LPL S447X allele frequencies between a general population and patients with LPL P207L deficiency.
Main Methods:
- Genotyping analysis of LPL, APOE, PPARalpha, and PPARgamma2 SNPs in a random Québec City cohort.
- Comparative analysis of LPL S447X allele frequencies between patient and general population cohorts.
Main Results:
- The rare LPL D9N allele was more prevalent than anticipated in the random cohort.
- LPL S447X allele frequency was significantly lower in LPL P207L deficient patients (4.4%) compared to the general population (11.2%).
Conclusions:
- The study highlights the importance of genetic screening for LPL D9N and S447X mutations.
- These screenings are vital for identifying individuals at risk for hypertriglyceridemia in the Québec population.